wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39767744-87D2385D-3C65-40D0-AD9E-25EAF4A68AE4
Q39767744-87D2385D-3C65-40D0-AD9E-25EAF4A68AE4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39767744-87D2385D-3C65-40D0-AD9E-25EAF4A68AE4
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.
P2860
Q39767744-87D2385D-3C65-40D0-AD9E-25EAF4A68AE4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39767744-87D2385D-3C65-40D0-AD9E-25EAF4A68AE4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8834fbb1b3b8d7ca8b37826826532252f913e739
P2860
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer.